Tejnaksh Healthcare Ltd
Tejnaksh Healthcare Ltd (TEJNAKSH) last reported results for the quarter ended Jun 2026, with sales of ₹2.65 crore and net profit of ₹0.26 crore. The stock last traded at ₹12.6, a market capitalisation of ₹25.6 crore, on a P/E of 20.6. Over the past 52 weeks the stock has ranged between ₹10.6 and ₹18.9. Figures are as of 6 Oct 2026 and are not real time.
Tejnaksh Healthcare Ltd share price and key metrics
- Current price
- ₹12.6
- Market cap
- ₹25.6 cr
- Stock P/E
- 20.6
- Book value
- ₹13.4
- ROE
- 4.67%
- ROCE
- 6.35%
- Dividend yield
- 0.00%
- 52w high / low
- 18.9/10.6
Metrics as of 6 Oct 2026. Not real time.
Track Tejnaksh Healthcare Ltd
Cruxal reads every Tejnaksh Healthcare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Tejnaksh Healthcare Ltd growth and returns
- 10 Years
- 8%
- 5 Years
- -3%
- 3 Years
- -4%
- TTM
- -13%
- 10 Years
- -1%
- 5 Years
- -10%
- 3 Years
- -10%
- TTM
- -38%
- 10 Years
- 1%
- 5 Years
- -26%
- 3 Years
- -28%
- 1 Year
- -34%
- 10 Years
- 13%
- 5 Years
- 9%
- 3 Years
- 7%
- Last Year
- 5%
Tejnaksh Healthcare Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹2.65 cr, up 0.4% from ₹2.64 cr a year earlier. Net profit was ₹0.26 cr, up 23.8% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 3.37 | 3.19 | 3.21 | 2.64 | 2.98 | 2.62 | 2.55 | 2.65 |
| Expenses | 2.21 | 2.05 | 2.5 | 2.04 | 2.21 | 1.93 | 1.84 | 1.96 |
| Operating profit | 1.16 | 1.14 | 0.71 | 0.6 | 0.77 | 0.69 | 0.71 | 0.69 |
| OPM % | 34.42% | 35.74% | 22.12% | 22.73% | 25.84% | 26.34% | 27.84% | 26.04% |
| Other income | 0.09 | 0.17 | 0.07 | 0.09 | 0.09 | 0.07 | 0.14 | 0.1 |
| Interest | 0.11 | 0.14 | 0.01 | 0.05 | 0.03 | 0.04 | -0.03 | 0.01 |
| Depreciation | 0.31 | 0.2 | 0.17 | 0.36 | 0.35 | 0.36 | 0.36 | 0.35 |
| Profit before tax | 0.83 | 0.97 | 0.6 | 0.28 | 0.48 | 0.36 | 0.52 | 0.43 |
| Tax % | 21.69% | 42.27% | 28.33% | 28.57% | 33.33% | 19.44% | 32.69% | 37.21% |
| Net profit | 0.65 | 0.56 | 0.42 | 0.21 | 0.33 | 0.28 | 0.35 | 0.26 |
| EPS (₹) | 0.31 | 0.30 | 0.25 | 0.12 | 0.15 | 0.15 | 0.18 | 0.13 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Tejnaksh Healthcare Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7.28 | 14.14 | 19.76 | 17.12 | 11.96 | 12.68 | 11.73 | 12.18 | 12.75 | 10.54 | 10.8 |
| Operating profit | 3.2 | 5.34 | 4.18 | 4.04 | 3.72 | 4.8 | 3.7 | 3.63 | 4.1 | 2.8 | 2.86 |
| OPM % | 43.96% | 37.77% | 21.15% | 23.60% | 31.10% | 37.85% | 31.54% | 29.80% | 32.16% | 26.57% | 26.48% |
| Net profit | 1.82 | 3.18 | 3.14 | 2.15 | 2.07 | 2.81 | 1.79 | 1.77 | 2.23 | 1.18 | 1.22 |
| EPS (₹) | 0.90 | 1.42 | 1.49 | 1.03 | 1.01 | 1.34 | 0.83 | 0.88 | 1.15 | 0.61 | 0.61 |
TTM is the trailing twelve months to the most recent quarter.
Tejnaksh Healthcare Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 2.21 | 2.21 | 10.16 | 10.16 | 10.16 | 10.16 | 10.16 | 10.16 | 10.16 | 10.16 |
| Reserves | 5.86 | 7.93 | 3.00 | 5.09 | 7.16 | 9.90 | 11.61 | 13.41 | 15.75 | 16.99 |
| Borrowings | 6.39 | 7.64 | 6.33 | 7.19 | 4.89 | 6.99 | 6.42 | 4.80 | 1.05 | 0.25 |
| Other liabilities | 1.07 | 1.98 | 2.78 | 2.47 | 2.36 | 2.56 | 3.04 | 2.99 | 3.35 | 2.65 |
| Total liabilities | 15.53 | 19.76 | 22.27 | 24.91 | 24.57 | 29.61 | 31.23 | 31.36 | 30.31 | 30.05 |
| Fixed assets | 13.60 | 15.33 | 16.97 | 17.37 | 15.04 | 15.38 | 23.42 | 23.22 | 21.16 | 20.23 |
| CWIP | 0.00 | 0.00 | 0.39 | 0.65 | 0.79 | 8.89 | 0.95 | 1.07 | 1.33 | 1.69 |
| Investments | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other assets | 1.92 | 4.43 | 4.91 | 6.89 | 8.74 | 5.34 | 6.86 | 7.07 | 7.82 | 8.13 |
| Total assets | 15.53 | 19.76 | 22.27 | 24.91 | 24.57 | 29.61 | 31.23 | 31.36 | 30.31 | 30.05 |
As reported by the company. Total assets equal total liabilities by construction.
Tejnaksh Healthcare Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 2.25 | 4.49 | 3.15 | 1.16 | 1.18 | 9.21 | 2.12 | 4.01 | 0.24 | 1.72 |
| Cash from investing | -8.03 | -3.24 | -1.55 | -1.21 | 1.56 | -10.59 | -1.40 | -1.01 | 3.66 | -0.28 |
| Cash from financing | 6.43 | -0.66 | -2.09 | 0.10 | -2.80 | 1.62 | -1.20 | -2.27 | -3.87 | -1.24 |
| Net cash flow | 0.65 | 0.59 | -0.50 | 0.05 | -0.06 | 0.24 | -0.48 | 0.73 | 0.03 | 0.19 |
| Free cash flow | -8.36 | 3.00 | 1.58 | -0.15 | 2.68 | 0.09 | 1.19 | 3.18 | 1.12 | 1.21 |
| CFO / operating profit | 70% | 104% | 94% | 41% | 13% | 187% | 46% | 120% | 17% | 91% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Tejnaksh Healthcare Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 29.19% | 32.23% | 27.11% | 17.45% | 13.97% | 17.03% | 11.13% | 10.48% | 12.71% | 6.35% |
| Debtor days | 0.00 | -0.77 | 3.51 | 11.30 | 14.34 | 16.41 | 49.16 | 15.58 | 52.96 | 75.49 |
| Inventory days | 130.36 | 220.84 | 254.58 | 179.69 | 283.89 | 185.07 | 173.44 | 232.80 | 223.53 | 297.01 |
| Days payable | 225.95 | 226.97 | 184.03 | 151.62 | 190.61 | 100.25 | 139.79 | 63.23 | 84.88 | 85.88 |
| Cash conversion cycle | -95.60 | -6.91 | 74.06 | 39.38 | 107.62 | 101.23 | 82.82 | 185.15 | 191.60 | 286.62 |
| Working capital days | 4.51 | -42.85 | 19.40 | 75.47 | 8.55 | 6.62 | 44.50 | 3.30 | 81.87 | 91.77 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Tejnaksh Healthcare Ltd shareholding pattern
Promoters held 73.83% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.00%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 73.83% | 73.83% | 73.83% | 73.83% | 73.83% | 73.83% | 73.83% | 73.83% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 26.16% | 26.17% | 26.17% | 26.16% | 26.17% | 26.17% | 26.16% | 26.16% |
| No. of shareholders | 4,067 | 4,496 | 4,493 | 4,552 | 4,550 | 4,452 | 4,414 | 4,395 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Tejnaksh Healthcare Ltd corporate filings
- Company announces re-appointment of Independent Director at AGM held on 29th September 2026Company Updatelow impact
Cruxal's analysis: Tejnaksh Healthcare Limited has conducted its 18th AGM where it approved the…
Read the full analysis - Corporate Voting Results Confirm Re-election of Key Directors at Tejnaksh Healthcare LimitedAGM/EGMhigh impact
Cruxal's analysis: Tejnaksh Healthcare Limited has successfully passed all four resolutions at its 19th AGM…
Read the full analysis - Shareholder Meeting / Postal Ballot-Outcome of AGMAGM/EGMmedium impact
- Respected Sir/Madam, Please refer attached closure of trading window intimation.Insider Trading / SASTlow impact
- Tejnaksh Healthcare Ltd files Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Tejnaksh Healthcare Ltd has submitted its Annual Report for the financial year 2025-26 to…
Read the full analysis - Tejnaksh Healthcare Limited Announces 19th Annual General Meeting and Seeks Approval for Material Related Party TransactionsAGM/EGMlow impact
Cruxal's analysis: Tejnaksh Healthcare Limited has scheduled its 19th Annual General Meeting (AGM) for…
Read the full analysis - Tejnaksh Healthcare Limited Reports Q1 FY2027 Financial Results with Standalone Net Profit of 29.11 lakhResultmedium impact
Cruxal's analysis: Tejnaksh Healthcare Limited has released its unaudited standalone and consolidated…
Read the full analysis - Tejnaksh Healthcare Limited Reports Q1 FY2027 Financial Results and Director ReappointmentBoard Meetinglow impact
Cruxal's analysis: Tejnaksh Healthcare Limited reported standalone revenue from operations of 1.84 crore for…
Read the full analysis - Tejnaksh Healthcare Limited schedules Board Meeting for June 2026 quarterly results and Independent Director reappointmentBoard Meetinglow impact
Cruxal's analysis: Tejnaksh Healthcare Limited has announced a board meeting scheduled for 13th August 2026…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.